Ibrain is a peer-reviewed english-language open-access journal published by Wiley-VCH in Germany, operating under an open-access model since 2022. The journal covers Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry.
Authors are required to pay an article processing charge to publish in Ibrain; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Ibrain has published 340 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
brain function, brain diseases, neuroscience
At a glance
ISSN
- 2313-1934
- electronic
- 2769-2795
Frequently asked questions
Is Ibrain peer-reviewed?
Yes — Ibrain operates a Anonymous peer review review process.
Does Ibrain charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Ibrain publish?
Ibrain publishes research in Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry.
What languages does Ibrain accept?
Ibrain accepts manuscripts in English.
What is the ISSN of Ibrain?
ISSN:
2313-1934 (print) · 2769-2795 (electronic).How do I submit a manuscript to Ibrain?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Ibrain?
Average time from submission to publication is approximately 10 weeks.